CAPTORTX (CTX)
Last updated: Data as of: Source: ESEF / ESPI / GPW
Price Chart
Key Statistics
52W High
89.20 PLN
52W Low
33.00 PLN
About CAPTORTX
Captor Therapeutics develops drugs based on targeted protein degradation technology. The most advanced project CT-01 is in a phase I clinical trial for hepatocellular carcinoma.
This description was generated with the help of AI and may contain inaccuracies. Please verify important information from official sources.
Communities
News
No news for CTX.
Company Details
Data sourced from GPW and OpenFIGI. Updated periodically — verify with official sources.
Similar companies — equity
Explore the market
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.